Screener
Upstream Bio, Inc. UPB Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 36,089 | 37,865 | 72,654 | 63,662 |
| General and administrative | 7,052 | 7,419 | 15,136 | 14,201 |
| Total operating expenses | 43,141 | 45,284 | 87,790 | 77,863 |
| Loss from operations | (42,368) | (44,347) | (85,983) | (76,360) |
| Other income (expense): | ||||
| Interest income | 2,659 | 4,431 | 5,713 | 9,174 |
| Other income (expense), net | 7 | (50) | (23) | (50) |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s total operating expenses?
- Upstream Bio, Inc. (UPB) reported total operating expenses of $43.14M in Q2 2026.
- How has Upstream Bio, Inc.'s total operating expenses changed year-over-year?
- Upstream Bio, Inc.'s total operating expenses decreased by 4.7% year-over-year, from $45.28M to $43.14M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Upstream Bio, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude